Towards organoid culture without Matrigel.

Kozlowski MT, Crook CJ, Ku HT. · 2021

Read Towards organoid culture without Matrigel. by Kozlowski MT, Crook CJ, Ku HT. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8664924.txt.

Introduction

Kozlowski, Crook, and Ku review ways to grow organoids without Matrigel, the gel most labs now use. Organoids are small cell clusters that copy organ function. They serve as stand-ins for organs such as liver, gut, and brain. Matrigel comes from mouse tumor cells and is poorly defined.

That vague mix hides which factors guide organoid growth. The review covers defined options to replace it. Teams can use processed tissue matrix from real organs. Synthetic gels offer a second path with known content. Gels made from engineered proteins form a third. The authors weigh each path for growth and care of organoids.

Catalog record

CREATORKozlowski MT, Crook CJ, Ku HT.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE89 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8664924

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Towards organoid culture without Matrigel By Mark T. Kozlowski, Christiana J. Crook, Hsun Teresa Ku Published in: Communications Biology DOI: 10.1038/s42003-021-02910-8 ABSTRACT Organoids—cellular aggregates derived from stem or progenitor cells that recapitulate organ function in miniature—are of growing interest in developmental biology and medicine. Organoids have been developed for organs and tissues such as the liver, gut, brain, and pancreas; they are used as organ surrogates to study a wide range of questions in basic and developmental biology, genetic disorders, and therapies. However, many organoids reported to date have been cultured in Matrigel, which is prepared from the secretion of Engelbreth-Holm-Swarm mouse sarcoma cells; Matrigel is complex and poorly defined. This complexity makes it difficult to elucidate Matrigel-specific factors governing organoid development. In this review, we discuss promising Matrigel-free methods for the generation and maintenance of organoids that use decellularized extracellular matrix (ECM), synthetic hydrogels, or gel-forming recombinant proteins. INTRODUCTION Organoids are multicellular structures derived from stem and progenitor cells that mimic the function and spatial organization of organs1. Organoids recapitulate important organ functions in vitro while remaining small in size and often free of interfering cell types such as vascular, nerve, or other undesired epithelial cells. For these reasons, organoids are used to study organ development2 and model various diseases such as cancers3, neural disorders4, and autism5; they are also used as pharmaceutical testing platforms6, model systems for CRISPR-CAS9-mediated treatment of genetic diseases7, and replacement organs for transplantation8,9. It is possible to culture organoids from induced pluripotent stem cells (iPSCs)10 or adult stem cells from patient tissues11, which may lead to personalized medicine. The wide range of clinical applications of organoids is the subject of a recent review by Drost and Clevers12. Many excellent reviews have been published about different organoid types, such as heart13,14, brain15–17, liver18,19, kidney20–22, pancreas23–25, and female reproductive tract26. Many organoids have been cultured in Matrigel, a material derived from the secretion of Engelbreth–Holm–Swarm mouse sarcoma cells and enriched for extracellular matrix (ECM) proteins27. In an early report of organoid culture, Sato and colleagues grew murine intestinal Lgr5+ stem cells in high concentrations of Matrigel supplemented with the growth factors WNT, Noggin, R-spondin, and EGF28. This culture system has been widely adapted for other organs such as the colon, stomach, and liver29–33. Related methods have been used to construct simulated versions of the inner ear34 and pancreas35–39, and the similarities between pancreatic and liver-organoid-generating cells suggest that methods used for making liver organoids may be applicable to the pancreas40. The many organoid-specific applications of Matrigel-based culture methods have been thoroughly discussed elsewhere41–43. Despite its versatility and affordability, Matrigel is extremely complex; proteomic analysis shows that it contains more than 1800 unique proteins44. The undefined nature of Matrigel makes it difficult to identify the signals necessary for organoid structure and function; this difficulty is compounded by lot-to-lot variations of Matrigel45–48. Furthermore, Matrigel may not contain all of the necessary components for proper organoid formation; gut organoids cultured in Matrigel lack the characteristic architecture of mammalian intestines, which could be due to a sub-optimal amount of laminin-511 and the absence of other cell types such as mesenchymal cells49,50. Finally, it has become increasingly clear that the mechanical properties in three-dimensional (3D) culture systems can have large effects on cell51, organoid52, tissue53, and organ development54,55. The mechanical properties, such as elastic modulus, pore size, stress relaxation, and creep56–59, cannot be easily separated from the chemical cues in the Matrigel-based culture systems. Furthermore, the mechanical properties of Matrigel samples are heterogeneous; local regions of such gels have been found to exhibit elastic moduli several times higher than the average modulus of the sample60,61. Finally, the fact that Matrigel is originated from mouse cells hampers its use in human clinical transplantation due to potential immunogenicity18. Given these limitations, there is an emerging need to develop Matrigel-independent organoid culture methods. In this review, we discuss recently-developed Matrigel-free techniques for the culture of organoids. We will review undefined matrices, focusing on ECM derived from decellularized tissues and collagen, and defined matrices, including synthetic polymer hydrogels and engineered ECM proteins (Fig. 1). Table 1 summarizes the advantages and disadvantages of each category of material. Table 2 summarizes studies that discuss the effects of elastic modulus on the organoid formation of various tissues.Fig. 1Methods of making organoids without Matrigel.Replacing the undefined medium of Matrigel is a major goal of organoid culture. We will discuss three main alternative media: (a) decellularized extracellular matrix and other derived proteins, (b) synthetic hydrogels, which generally incorporate cell-adhesive domains or proteolytic degradation sites, and (c) gel-forming recombinant peptides. Adding multipotent cells to these matrices enables the growth of organoids, which are potentially applicable as transplants, drug-testing platforms, personalized medicine, and means to understand organ development.Table 1Different types of materials for the generation of organoids from various tissues in three-dimensional culture.MaterialsAdvantagesDisadvantagesOrganoids made using this type of materialReferencesMatrigelInexpensive and commercially available, extensively used with well-developed protocolsUndefined culture system, subject to lot-to-lot variation, poor control of mechanical properties, may not contain all chemical cues necessary for differentiation, immunogenicityGut, heart, brain, liver, kidney, pancreas, female reproductive tract, inter alia.See references12–27 for reviewsDecellularized tissuePreserves native chemical cues and mechanical properties, resulting organoids can be largePreparation is difficult, limited by donor availability, lack of definitionLiver, intestine, heart, lung, kidney, pancreas, testicular, stomachLiver:73–77,80 Intestine:79,80 Heart:69,70 Lung:70,71,121 Kidney:67,68,70 Pancreas:80–82 Testes:72 Stomach80:Collagen and other biomacromolecules derived from natural sourcesLow cost, wide availabilityNo structural information preserved, not all necessary chemical cues present, often requires feeder cells, lot-to-lot variationLiver, intestine, pancreas, epithelium, brain, lung, vascular, stomach, kidneyLiver:98 Intestine:84–86,89–91,102,103 Pancreas:104 Epithelium:86,88,89 Brain:101,111–116 Lung:99,100 Vascular:105 Stomach:85,102 Kidney:87Synthetic polymersExcellent control of mechanical and chemical properties, repeatability, tunable degradation rateRequires functionalization with cell-binding peptides or presence of feeder cells, possible cytotoxicity concernsBrain, liver, intestine, pancreas, salivary glandsNeural and Brain:156,157,161,165,169,174 Liver:158–160,179 Intestine:162–164 Pancreas:175 Salivary Glands:183Recombinant proteins and peptidesPrecise placement of chemical cues, tunable mechanical properties, tunable degradation rate, easy to include cell-binding domainsPossible endotoxin contamination, higher cost, possible immunogenicityPancreas, brain, intestine, heartPancreas:192–195 Brain:196,198–202 Intestine:191 Heart:189,190Table 2Ideal elastic moduli for generating organoids from different organs.OrganoidIdeal matrix elastic modulusReferencesMouse ESC-derived neuroepithelial2–4 kPa156,157Mouse liver6–20 kPa179Human intestineMouse intestine100–200 Pa100–200 Pa162–164,191Human brainHuman fore-brainHuman hindbrain100 Pa–1 kPa300 Pa1 kPa51,114,197116116Mouse heart700 Pa190Mouse bone34 kPa51 ORGANOID CULTURE IN DECELLULARIZED ECM AND OTHER NATURALLY-DERIVED PROTEINS In organ development, ECM proteins provide signaling cues, serve as an adhesive substrate, and sequester growth factors (Fig. 2)62. In order to accurately recapitulate the composition, structure, and vascularization of native ECM in organ development, some organoids have been grown in decellularized ECM from human or animal donors. The methods of decellularization used are dependent on the target tissue and not readily generalizable; a number of these methods have been reviewed elsewhere63. While xenogeneic ECM has the potential to cause immune responses, this risk can be greatly reduced by using proper preparation techniques64; similar ECM scaffolds derived from animals are FDA-approved for clinical applications such as heart valve replacement, facial reconstruction, and osteopathic implants62,65. Decellularized ECM may also provide additional cues that promote regeneration of damaged tissue, ultimately supporting the organoid transplant and promoting its function66. Decellularization approaches have been demonstrated for human kidney67, murine kidney67,68, murine heart69,70, human and porcine lung71, and porcine testicular72 tissues, with each type posing unique challenges. To illustrate some of these challenges and

Read the complete text